Other languages AbbVie Inc. NEO Exchange

Equities

ABBV

CA00288K1084

End-of-day quote NEO Exchange Other stock markets 18:00:00 2024-07-01 EDT			5-day change	1st Jan Change
24.2 ^CAD	-3.20%		-2.89%	+6.75%

07-01	Merus Names New Chief Medical Officer	MT
07-01	AbbVie: new CEO takes up post	CF

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Merus Names New Chief Medical Officer	07-01
AbbVie : le nouveau directeur général prend ses fonctions	07-01
AbbVie Says Robert Michael Assumes CEO Role	07-01
Blackrock : Boeing, Meta...les valeurs à suivre aujourd'hui à Wall Street	07-01
AbbVie : Robert A. Michael prend les commandes d’AbbVie	07-01
AbbVie Announces Board Changes	07-01
Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU	06-28
AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment	06-28
AbbVie Receives Positive CHMP Opinion for Epcoritamab for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma	06-28
Sector Update: Health Care Stocks Slipping Late Afternoon	06-27
Sector Update: Health Care Stocks Decline in Afternoon Trading	06-27
AbbVie : acquisition de Celsius pour 250 millions de dollars	06-27
AbbVie Buys Celsius Therapeutics for $250 million	06-27
AbbVie Buys Celsius Therapeutics for $250 million	06-27
Nxera Pharma Co Achieves Key R&D Milestone in Collaboration with AbbVie; Secures $10 Million Payment	06-27
Nxera Pharma Co., Ltd. Receives USD 10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone	06-26
U.S. Food and Drug Administration Grants Second Approval for AbbVie's EPKINLY (epcoritamab-bysp) to Treat Patients with Relapsed or Refractory Follicular Lymphoma	06-26
AbbVie Inc. acquired Celsius Therapeutics, Inc. for $250 million.	06-26
AbbVie Issues Regulatory Update on New Drug Application for ABBV-951 to Treat Parkinson's Disease	06-25
US FDA declines to approve AbbVie's Parkinson's disease therapy	06-25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages AbbVie Inc. NEO Exchange

Equities

ABBV

CA00288K1084

Other languages

Filters